ArticleEMBO molecular medicine2024

ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer.

Chiara Pozzato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.